NEW YORK (GenomeWeb) – ArcherDX said today that it is acquiring genetic carrier screening firm Baby Genes for undisclosed terms.

Baby Genes will operate as a wholly owned subsidiary and market its existing menu of tests under the new name ArcherDX Clinical Services.

Existing ArcherDX research and development functions will remain in the firm's Boulder, Colorado lab, while all commercial genetic profiling services for both companies will be consolidated in Baby Genes' Golden, Colorado CLIA-certified, CAP accredited lab.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.

South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.

In Science this week: the synthetic genetic system hachimoji, and more.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.